Invesque (IVQ) AI Stock Analysis

• Market Cap: C$9.56M
• Dividend Yield: N/A
• Average Volume (3M): 130.88K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.05
• Revenue Growth: -9.56%
• EPS Growth: 25.10%
• Country: CA
• Employees: 18
• Sector: Real Estate
• Sector Strength: 72
• Industry: Real Estate
• EPS (TTM): -1.64
• Shares Outstanding: 56,225,170
• 10 Day Avg. Volume: 88,529
• 30 Day Avg. Volume: 130,881
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.04
• Price to Cash Flow (P/CF): 0.40
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Invesque faces significant challenges with negative profitability, high leverage, and cash flow constraints, as reflected in its low financial performance score. Technical analysis indicates neutral momentum, with no strong trends evident. The valuation remains concerning due to a negative P/E ratio and lack of dividends. These factors collectively highlight the company's financial instability and operational risks, resulting in a low overall stock score.

Invesque Business Overview & Revenue Model

Company Description

Invesque (IVQ) is a real estate investment company that focuses on the acquisition, ownership, and management of a diversified portfolio of healthcare and senior living properties across North America. The company primarily invests in skilled nursing facilities, independent living, assisted living, and memory care properties, leveraging its expertise and experience to deliver value for its shareholders and residents.

How the Company Makes Money

Invesque makes money through the leasing and management of its healthcare and senior living properties. The company generates revenue by collecting rent from its tenants, which include operators of healthcare facilities such as skilled nursing and senior living communities. Additionally, Invesque may engage in strategic partnerships and joint ventures with healthcare operators to enhance its portfolio and optimize asset performance. The company's earnings are influenced by factors such as occupancy rates, lease renewals, property acquisitions, and the overall demand for senior living and healthcare services.

Invesque Financial Statement Overview

Summary

Invesque's financial statements reflect challenges with negative profitability and high leverage. The income statement shows declining revenue and profitability, while the balance sheet indicates financial risk due to high debt. Cash flow constraints further exacerbate these issues, though there are signs of operational cash generation. Overall, the company faces significant financial hurdles that require strategic adjustments to improve stability and profitability.

Income Statement

The TTM (Trailing-Twelve-Months) income statement shows declining revenue and gross profit margins compared to the previous year. EBIT and EBITDA margins are negative, indicating operational challenges. The net profit margin is also negative, reflecting significant net losses. Despite these weaknesses, the company has managed to maintain some revenue, but the overall trajectory suggests financial distress.

Balance Sheet

The balance sheet reveals high leverage with a debt-to-equity ratio exceeding 4x in the latest TTM period, highlighting financial risk. The equity ratio has decreased, indicating reduced financial stability. However, some equity remains, providing a buffer against liabilities. Overall, the balance sheet suggests vulnerability due to significant debt levels.

Cash Flow

Cash flow analysis shows a decline in operating cash flow and negative free cash flow in the TTM period, indicating cash constraints. However, the operating cash flow to net income ratio remains positive, reflecting some ability to generate cash from operations despite net losses. The free cash flow trend is concerning, but the company has managed to reduce negative free cash flow compared to earlier periods.

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
175.41M	192.83M	198.03M	210.45M	217.39M	144.69M
	Gross Profit
69.09M	76.49M	95.59M	90.97M	108.39M	95.31M
	EBIT
12.93M	27.74M	32.43M	34.11M	-14.74M	57.31M
	EBITDA
-666.00K	-18.83M	10.38M	49.13M	-101.52M	52.73M
	Net Income Common Stockholders
-67.89M	-99.24M	-42.01M	-28.54M	-184.00M	-5.36M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
10.74M	10.74M	27.58M	19.37M	34.13M	11.84M
	Total Assets
828.28M	828.28M	1.10B	1.30B	1.50B	1.63B
	Total Debt
588.25M	588.25M	765.46M	893.75M	1.05B	1.01B
	Net Debt
577.50M	577.50M	737.88M	874.38M	1.02B	1.00B
	Total Liabilities
681.70M	681.18M	865.69M	1.01B	1.21B	1.15B
	Stockholders Equity
146.59M	146.59M	231.65M	286.26M	293.33M	480.14M
Cash Flow		Free Cash Flow
-1.02M	217.00K	5.40M	11.11M	13.82M	-219.26M
	Operating Cash Flow
3.69M	6.03M	11.91M	18.68M	25.09M	16.17M
	Investing Cash Flow
117.27M	132.05M	137.49M	119.19M	2.98M	-309.97M
	Financing Cash Flow
-126.87M	-154.92M	-141.19M	-152.63M	-5.78M	278.66M

Invesque Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.17
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IVQ, the sentiment is Negative. The current price of 0.17 is below the 20-day moving average (MA) of 0.17, above the 50-day MA of 0.14, and above the 200-day MA of 0.17, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 51.50 is Neutral, neither overbought nor oversold. The STOCH value of 26.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:IVQ.

Invesque Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EXE	81 Outperform	C$1.09B	14.65	70.86%	3.67%	12.36%	123.26%
SIA	66 Neutral	C$1.45B	31.80	8.99%	5.92%	13.72%	429.22%
Sector *	61 Neutral	$4.76B	18.86	-2.89%	8.05%	6.45%	-20.33%
IVQ	45 Neutral	C$9.56M	―	-41.49%	―	-9.56%	25.10%

Invesque Corporate Events

Invesque Inc. Corrects Debenture Principal Amount

Invesque Inc. announced a correction to the aggregate principal amount of its Amended Debentures, clarifying that the correct amount is US$27,300,000 rather than the previously stated US$23,700,000. This correction does not alter any other information disclosed in their prior release, ensuring transparency for stakeholders and maintaining investor confidence in their financial disclosures.

Invesque Finalizes Key Debenture and Share Exchange

Invesque Inc. has successfully completed the exchange of its debentures and preferred shares, resulting in a significant reduction of their annual interest expenses. The exchanges have led to Magnetar controlling 80% of Invesque’s outstanding common shares, marking a pivotal step in the company’s strategic evolution.

Invesque Inc. Gains Approval for Debenture Amendments

Invesque Inc. has received substantial approval from debenture holders and shareholders for amendments to its convertible debentures and the exchange of preferred shares for common shares. This strategic move is expected to be finalized by the end of December 2024, marking a significant step towards optimizing the company’s capital structure.